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INTRODUCTION 
Anatomy, cell types and connectivity of the pedunculopontine 
nucleus  
The pedunculopontine nucleus (PPN) is a structure in the 
midbrain extending in a rostrocaudal direction bordered medially by the 
superior cerebellar peduncle, laterally by the lateral lemniscus, and 
rostrally the substantia nigra.  The parabrachial nucleus provides the 
caudal borders of the nucleus while the PPN is surrounded by the 
cuneiform and precuneiform nuclei in the dorsal direction.  The pars 
dissipata corresponds to the rostral while the pars compacta corresponds 
to the caudal part of the PPN.  In addition to numerous cholinergic cells 
it contains GABAergic and glutamatergic neurons, which appear in 
different proportions and densities along the PPN rostrocaudal axis.  
The number of cholinergic and glutamatergic neurons increases in the 
caudal region of the nucleus whereas that of the GABAergic neurons 
increases in the rostral direction. 
The PPN receives inputs from several regions such as the spinal cord, 
superior colliculus, nucleus propositus hypoglossi, entopeduncular 
nucleus, subthalamic nucleus, substantia nigra pars reticularis and the 
cortex. The axon collaterals of cholinergic neurons follow ascending 
dorsal and ventral pathways. The dorsal pathway innervates the superior 
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and inferior colliculi and the thalamus. Synapses of the ventral pathway 
are detectable in some regions of the basal ganglia, and the substantia 
nigra as well as in the regions of ventral tegmental area, subthalamic 
nucleus, lateral hypothalamus, ventral pallidum, amygdala, mediolateral 
septum and the striatum.  The descending projections of the cholinergic 
neurons provide innervation of the nucleus pontis oralis, the 
gigantocellular nucleus and the spinal cord. The descending projections 
of cholinergic neurons provide innervation of the oral pontine reticular 
nucleus, the gigantocellular nucleus, and the spinal cord. A great deal 
less information is available on the synapses of the GABAergic and 
glutamatergic neurons. Their axons possess less collaterals and their 
pathways are restricted to the midbrain structures and the caudal region 
of the brainstem.  
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Physiological roles of the PPN   
The PPN is part of the reticular activation system (RAS), which 
plays a role in, among other things, regulating the sleep-wakefulness 
cycle and movement as well as sensory gating. During wakefulness and 
REM sleep PPN cholinergic neurons fire at higher frequencies than 
during slow-wave sleep, thereby showing that RAS plays a role in the 
regulation of the cortical active state. However, it has been 
demonstrated that damage to the nucleus causes no changes in the full 
sleep-wakefulness cycle. The question then arises what role cholinergic 
neurons of the nucleus may play in determining sleep-wakefulness 
cycles. Examination of the activity of the cholinergic neurons of the 
nucleus in in vivo experimental conditions revealed that their activity is 
episodic, contradicting the assumption that tonic activity is necessary to 
maintain wakefulness. It is the M-current and the astrocyte dependent as 
well as endocannabinoid-mediated processes that are responsible for the 
transient nature and control of the cholinergic neurons. In addition to 
the cholinergic neurons the GABAergic and glutamatergic neurons of 
the PPN also play a role in wakefulness state and cortical activation. 
The role of the PPN in sensory gating can be observed on the 
startle reflex and its prepulse inhibiton. The startle reflex is a sudden, 
rapid motor response to potentially harmful effects. Reflex amplitude 
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decreases in progressive supranuclear palsy, while in schizophrenia a 
decrease in prepulse inhibiton is observed. Using selective optogenetic 
activation of cholinergic neurons it has been demonstrated that 
stimulation of PPN cholinergic neurons increases startle reflex 
amplitude without influencing prepulse inhibition. Activation of non-
cholinergic neurons is likely to be responsible for the latter.    
It is a well-known fact that the PPN is part of the mesencephalic 
locomotors region. Stimulation of this region inn different locations 
creates diverse movement patterns. It has been demonstrated in 
electrophysiological experiments that this may be attributed to the 
stimulation of the different neuron subpopulations. Stimulation of the 
PPN inhibits movement by decreasing muscle tone, while the cuneiform 
nucleus situtated dorsally to the PPN increases muscle tone and 
stimulates movement.    
 
Functional classification of PPN neurons 
Examination of the different subgroups of the PPN has been 
conducted by several workgroups. These examinations used primarily 
NADPH diaphorase, neuronal nitrogen-monoxide synthetase (bNOS) 
and choline acetyltransferase ChAT) immunohistochemical 
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identification. These methods made cholinergic neurons visible; 
however, no examinations have previuosly been carried out on 
transgenic mice.    
 
Cell-level classification  
Based on the membrane properties of neurons, in 1990, Kang 
and Kitai identified low threshold spiking (LTS) cells and named them 
Type I cells, while the neurons with A-current (transient outward 
current) and LTS were identified as Type II. A third group was also 
established for cells that did not possess either of the above properties.  
In 1988 Leonard and Llinas also established three categories. In their 
classification, Type I contained neurons that had LTS, Type II 
contained neurons with A-current and Type 3 contained neurons that 
possessed both properties that the other two types had. Classition by 
Takakusai et al., and Ye et al. was in accordance with the 1988 
grouping. Takakusaki et al. classified cell groups that simultaneously 
possessed both A-current and LTS as II/2, while they belonged to Type 
III in Ye et al.’s classification. The latter workgroup named neurons that 
did not have either of the above properties Group IV. In addition to the 
above properties (A-current and LTS) M-current (slowly activating, 
non-inctivating voltage-gated potassium current) and HTO (High 
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threshold membrane potential oscillation) are also important markers of 
cholinergic neurons.  The presence of these properties in cholinergic 
neurons alone was demonstrated by Bordás et al. in 2015.  
 
In vivo electrophysiological classification  
In vivo classification is based on the firing properties of neurons 
and their cortical activity, which served to distinguish two main groups 
of cholinergic neurons. The firing frequency of cholinergic neurons 
during the active periods of cortical slow wave activity and gamma 
activity was low (0.9 Hz). On the other hand, high action potential 
firing frequency was found (31 Hz) in neurons firing primarily during 
the second half of the passive periods of slow wave activity and were 
independent of gamma oscillations. Non-cholinergic neurons fell into 
one of three populations: „silent neurons”, „tonically firing neurons”, 
and „irregularly firing” neurons. A further classification of PPN 
neurons can be carried out in terms of their relationship to REM and 
non-REM sleep. The main groups are as follows: neurons active during 
wakefulness and REM sleep, neurons active during REM sleep and 
neurons active during wakefulness. 
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Astrocyte-neuron communication  
Astrocytes are cells that belong to macroglial cells and play a 
role in the functioning and regulation of neurons. One of their recently 
recognised tasks is the regulation of synapses, playing a role as a third 
component in a so-called „tripartite synapse". They also participate in 
the setting of synaptic neurotransmission. They also release 
gliotransmitters. They contribute to neuronal homeostasis, regulate 
potassium ion concentration and mediate uptake and elimination of 
several important neurotransmitters, including glutamate. They 
contribute to certain neuromodulatory effects and synchronisation of 
neuronal networks. In addition to their physiological role, their 
pathological significance is also known; they contribute to the 
development of several diseases (including neuropsychiatric and 
neurodegenerative disorders).  Astrocytes are not electrically excitable, 
are incapable of action potential firing, however, by changing the 
intracellular calcium concentraton, they generate calcium waves, 
resulting in the release of various gliotransmitters. One of the most 
important gliotransmitters is glutamate. By regulating extrasynaptic 
neurotransmitter concentration astrocytes are able to influence neuron 
excitability.  
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Astrocyte-dependent currents stimulating neuronal excitability  
Slow inward currents (SIC) are phasic extrasynaptic excitatory 
events that are consequences of astrocyte activation, distinguished from 
excitatory postsynaptic currents (EPSC). SICs have larger amplitudes as 
well as slower rise and decay times than EPSCs. SICs are thought to be 
consequences of extrasynaptic, GluN2B-containing NMDA receptors 
that are freely detectable in the central nervous system. Astrocyte 
stimulation elicits generation of SICs on neighbouring neurons while 
astrocyte inhibition prevents their generation. These events are related 
to changes in the intracellular calcium concentration of astrocytes. Our 
workgroup has demonstrated that, in the presence of TTX, the 
frequency of SICs does not change but its amplitude decreases in the 
PPN, which suggests that SICs are probably consequences of astrocyte-
neuron interactions. Kinetics of the event are greatly affected by 
gliotransmitter concentration and the number of transmitter receptors.  
Tonic inward currents are slow, non-adapting currents, and their 
relationship with astrocytes is less straightforward. They are thought to 
be consequences of mainly, although not exclusively, extrasynaptic 
glutamate- and glycine-mediated events and to occur simultaneously 
with SICs.  
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Features of PPN SICs and neuromodular effects exerted on them  
Like in other parts of the brain, SICs generated on PPN cells are 
characterised by slower kinetics and larger amplitudes than excitatory 
postsynaptic currents.  The features of PPN slow inward currents are as 
follows: (1.) They are consequences of astrocyte activation, 
consequential glutamate release and activation of extrasynaptic, 
GluN2B-containing NMDA receptors. (2.) PPN SICs occur in both 
cholinergic and non-cholinergic neurons in the same proportion, thus 
they are not related to the neurochemical cell types of PPN neurons. (3.) 
SICs do not synchronise neighbouring neurons. (4.) Their occurrence 
greatly depends on the neuron-astrocyte distance. (5.) –
Neuromodulatory actions on SICs depends on the original SIC activity. 
(6.) The neuromodulatory effects observed on SICs are likely 
consequences of NMDA receptor desensitisation. 
 
Orexinergic neuromodulation  
Orexins also affect PPN cells. Two types of this peptide, 
released from orexinergic neurons in the lateral hypothalamus are 
known: orexin-A and orexin-B. It exerts its effect through Gq-protein 
coupled receptors, OXR1 and OXR2, which are present in different 
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parts of the brain. It was originally identified as a hormone related to 
food uptake. Today we are familiar with its role in the regulation of 
sleep and wakefulness. Furthermore, it is also recognised as a 
participant in several pathophysiologocal processes, including 
narcolepsy. In mice, loss of prepro-orexin leads to a condition similar to 
human narcolepsy with daytime sleepiness and cataplexy. Loss of 
OXR2 resulted in milder symptoms but lack of OXR1 did not affect 
wakefulness stability.  In people with narcolepsy there was a marked 
lack of orexinergic neurons and decrease in the quantity of orexin. 
Proopiomelanocortin (POMC) and the NPY-expressing neurons of the 
arcuate nucleus provide neuronal inputs to orexinergic neurons.  This 
indicates a relationship between the orexinergic system and food 
uptake.  The fact that calory intake decreases in patients with 
narcolepsy while body mass index increases also suggests some further 
relationship. In addition to the above, several other roles have been 
attributed to orexin, of which the one related to reward should be 
highlighted. The orexinergic neurons project into several areas of the 
reward system, including locus coeruleus, the ventral tegmental area or 
nucleus accumbens.   
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OBJECTIVES 
Our aim was to examine whether the earlier in vitro 
electrophysiological classification of PPN neurons, which was 
primiarily based on the immunohistochemical properties of cholinergic 
neurons, are indeed valid in cholinergic neurons identified using 
transgenic techniques.  We sought to answer the following questions: 
1. Is tdTomato really expressed in cholinergic neurons?  
2. Can functional subgroups according to former categories be identified 
in transgenic mice? 
3. Does a new functional classification of cholinergic neurons, different 
from earlier groupings exist? 
4. Do the neurons that have different functional properties possess a  
rostrocaudal gradient?  
5. Are the different functional and morphological properties of cholinergic 
neurons related to one another?  
Further, we wished to examine the effect of orexin as a neuromodulator 
affecting PPN neuron, including: 
1. We wished to examine the effect of orexin on SICs. 
2. We looked for the existence of a common astrocyte-dependent 
neuromodulatory action. 
14 
 
MATERIALS AND METHODS  
Solutions  
In our experiments artificial cerebrospinal fluid (aCSF) with a pH of 
7.4 was used while the midbrain slices were prepared in ice-cold low 
Na+ artificial cerebrospinal fluid („low Na aCSF”), where 95 mM NaCl 
was replaced by glycerol (60 mM) and sucrose (130 mM). For the 
recordings, tetrodotoxin (TTX)-citrate, CdCl2, orexin-A, 2,3dihidroxi-6-
nitro-7-sulfonamil-benzol[f]quinoxalin (NBQX) D-(-)-2-amino-5-
phosphono pentanoate (D-AP5), bicucullin and strychnine were used.  
As the internal solution of the pipette used for recordings a potassium-
gluconate based solution with a pH of 7.3 was used and biocytin was 
added immediately before the recordings.    
Animals, tissue preparation  
In our study 9-22 day-old mice were used (n= 92). A larger group of 
transgenic mice expressed tdTomato fluorescent protein in a choline 
acetyltransferase-dependent way (ChAT-tdTomato), another group 
expressed tdTomato in Type 2 vesicular glutamate transporter-
dependent way (Vglut2-), and a smaller group in a glial fibrillary acidic 
protein-dependent way (GFAP-tdTomato). For mouse crossing the cre-
lox system was used. In this system, one parent is involved in the 
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promoter-specific expression of cre-recombinase and the other parent’s 
genome has the protein to be expressed whose transcription was 
inhibited by a stop codon surrounded by lox-P sites.  For the crossing, 
as a result of the cleavage of the stop codon, the protein occurs in a 
promoter-specific way. The mice were decapitated, the brains were 
carefully removed and, using a vibratome, 200 μm coronal slices were 
prepared. During the entire process the slices were kept in ice-cold low 
Na+ aCSF. Following the fast preparation, the slices intended for use 
were kept in normal aCSF for 60 minutes at 37 ºC and oxygenated.   
Electrophysiology  
Whole-cell patch-clamp recordings and data acquisition were 
performed in magnesium-free naCSF at room temperature containg the 
following systems: Axopatch 200A amplifier, Zeiss Axioskop 
microscope with fluorescent imaging system with further components: 
Polychrome V5 light source and a CCD camera with an imaging unit. 
Recording and data acquisiton were carried out using Clampex 10 
software while for analysis Clampfit 10 programme was used. The 
slices were continually washed in oxygenated aCSF during the 
recordings, too, uisng a peristaltic pump. Patch pipettes with 6–8 MΩ 
pipette resistance were prepared using Narishige P-10 puller.  
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The following recordings were performed in current-clamp 
configuration, using 1 s current steps between -30 pA and +120 pA, in 
10 pA increments. Resting membrane potential was kept at -60 or -80 
mV. Input resistance, maximum firing frequency, average firing 
frequency, action potential delay, adaptation index, existence and 
amplitude of low threshold spikes and rebound spikes were recorded.  
For high threshold membrane potential oscillations 2 s, ramp 
depolarising current injection rising from 0 pA to 800 pA was used. In 
some cases simultaneous recordings were made on the somata and 
proximal dendrites of the same cholinergic cells. A-current and all 
orexin-dependent events were recorded in  voltage-clamp configuration. 
Neuron reconstruction 
To visualise cholinergic cells biocytin was used. It was placed in 
the internal pipette solution immediately before the measurement and 
then reached the inside of the cell during the recordings. After the 
recordings the slices were fixed overnight . Antigen retreval was 
performed in Tris Buffered saline solution completed with 0.1% Triton-
X-100 and 10% bovine serum for 60 minutes. The slices were incubated 
for 90 minutes using Alexa 488 conjugated streptavidin, and then 
photomicrographs were taken using a Zeiss LSM 510 confocal 
microscope. Cells were reconstructed using Neurolucida software while 
17 
 
to record and visualise topography we relied on the contours and 
parameteres of the Paxinos mouse brain atlas.   
In three cases choline acetyltransferase immunohistochemistry was used 
on slices prepared from transcardially perfused ChAT-tdTomato mice 
with a view to assessing the overlap between tdTomato expression and 
ChAT immunopositivity.   
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RESULTS  
 
There is considerable overlap between ChAT 
immunohistochemistry and tdTomato expression  
We carried out our invstigation in 3 ChAT- tdTomato mice by 
manually analysing 379 cell bodies.  98± 1% of tdTomato positive cell 
bodies were found to be ChAT positive.  When all cells that were either 
tdTomato expressed or ChAT-immunopositive were considered, 86,8% 
± 3,5% of the examined cells overlapped.  11,9 ± 3,3% of the examined 
cells were only ChAT immunopositive while 1,76 ± 0.9% showed only 
tdTomato expression. Thus, tdTomato expression proved to be a 
suitable marker that can be efficiently used to identify cholinergic 
neurons. 
 
There is a correlation between the orientation of neuron dendrites  
and the existence of LTSs  
We examined the orientation of dendrites originating from the 
somata in 17 neurons, 4 of which had a bipolar dendritic tree, in other 
words, the two longest processes were arranged in opposite directions. 
The rest of the neurons were multipolar with the dendrites pointing in 
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more than two directions. As a relationship between the orientation of 
dendrites and the functional properties of neurons we found that, cells 
with LTS are bipolar while those without LTS tend to be multipolar.  
We classified a total of 91 genetically identified cholinergic neurons 
along the following lines: 
 Type I neurons: had low threshold depolarising spikes (LTS) 
and rebound spikes. 
 Type II neurons: possessed A-current and were characterised 
by hyperpolarisation-induced delay. 
 Type III neurons: were characterised by LTS and A-current 
as well as hyperpolarisation-induced delay. 
 Type IIIK neurons: had none of the above properties.  
We were able to clearly determine rostrocaudal localisation of the 
somata in 33 cases.  12 of these were Type I neurons, 45.45% belonged 
to Type II, 21.21% to type III, and another 21.21% to Type IIIK. We 
identified 13 neurons in the pars compacta of the PPN, in which the 
dominant type of neurons were Type II with 69.2%, Types I and III 
neurons were represented by 7.69% each and Type IIIK by 15.38%.  In 
the rostral part of the PPN we identified 20 neurons, of which 15% were 
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Type I neurons, 30% Type II. and Type III, respectively, and 25% were 
Type IIIK.  
There were relatively few neurons (15.4%) in the pars compacta of the 
PPN that had LTS or rebound firing (Types I and III). The 
corresponding ratio in the pars disspata was 47.3%.  
 
Type III neurons have smaller maximum frequencies and smaller 
average firing frequencies  
Type III. neurons had significantly smaller maximum firing 
frequencies than did Types I and IIIK. In Type III neurons maximum 
firing frequency was 16.49 ± 1.99 Hz, in Type I it was 30.76 ± 5.04 Hz, 
in Type I. neurons it was 23.99 ± 1.69 Hz with 32.94 ± 7.44 Hz in Type 
IIIK. We obtained similar results with regards to average firing 
frequency. Average firing frequency of Type III neurons was 7.06 ± 
1.54 Hz during 100 pA current injection, compared with 14.16 ± 3.24,  
11.3 ± 0.94, and 12 ± 2.3 Hz in Type I, II, and IIIK groups, 
respectively.   
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Neurons with A-current can be either early or late firing  
We further classified neurons that were characterised by firing delays 
larger than 50 ms at resting membrane potential. Neurons with A- 
current can be classified into two subgroups: 
1. The group of early firing neurons, where the occurrence of the first 
action potential from the beginning of the stimulus was less than 250 
ms.  
2. The group of late firing neurons, where latency was longer than 250 ms. 
Thus the second group represents a smaller subgroup of cholinergic 
neurons with A-current that are located caudally. 
Average latency in the pars compacta was 205.3 ± 59 ms 
compared with 71.4 ± 15.5 ms in the pars dissipata. This can lead us to 
conclude that average latency in the caudal neurons was significantly 
longer than  the examined rostral neurons.  
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High threshold membrane potential oscillations 
 
Our workgroup has previously demonstrated that HTOs are a 
characteristic feature of cholinergic neurons and this study has 
confirmed that finding. 
Oscillation frequency of the neurons located in  the caudal part 
of the PPN was higher (23.07 ± 4.9 Hz) and their amplitudes were low 
(6.59± 3.8 mV2/Hz power), while in the rostral part of the PPN 
frequency of oscillation was low (12.08 ± 2.01 Hz), with greater 
amplitudes (18.85 ± 5.08 mV2/Hz power). In order to confirm the 
relationship between firing frequency and oscillation frequency we used 
CdCl2 in our later recordings to block oscillations. Parallel to the 
inhibition of oscillation activity, the firing frequency of the action 
potentials increased significantly from 6.71 ± 104 to 15.38 ± 1.42 Hz.  
We looked for the place of origin of the oscillations while 
making simultaneous dendritic and somatic patch clamp recordings. 
Oscillation on the dendrites was characterised by lower (9.77 ± 6.57 
mV2/Hz) power compared to the data of the somata (20.13 ± 8.55 
mV2/Hz power) and frequency was almost identical on the two (1,41 
Hz). It is clear that the value of oscillation power recorded on the 
dendrites was 39.7 ± 12% of those recorded on the somata with 
frequency being practically the same (102 ± 11%). This ratio 
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corresponds to that found during the passive spread of the electric 
impulses from the somata to the dendrites.   
 
The effect of orexin on tonic currents, EPSCs and low threshold 
oscillation activity      
The neuromodulatory actions (muscarinic cholinergic, 
serotoninergic, and cannabinoid) that have been examined so far have, 
at least partly in an astrocyte-dependent way, elicited tonic inward 
currents on some neurons and tonic outward currents on some other 
neurons.  In contrast with the above neuromodulators, the only effect 
orexin exerts is depolarisation of PPN neurons. During our experiments 
we examined whether orexin, which affects tonic currents in a way 
different from that of other examined neuromodulators, also affects 
SICs differently from other neuromodulators.    
We conducted all our experiments involving orexin in a 
nominally magnesium-free solution in order to make the spontaneous 
occurrence of SICs more likely. Using 200 nmol/l orexin-A we 
recorded a -17.32 ± 3.11 pA amplitude tonic inward current, which was 
significantly different from the -0.98 ± 3.11 pA amplitude fluctuation of 
the holding membrane potential recorded in control conditions. Parallel 
to the development of the tonic current sEPSC frequency increased 
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significantly. There was no significant increase in sEPSC amplitude but 
it did show an increasing tendency.  
sEPSC frequency increased to 279 ± 41% of the control during orexin 
application, and its amplitude rose to 119 ± 12% of the control. Orexin 
also activated noise-like low threshold oscillations.  Fittings the power 
spectra of currents under control conditions and with orexin with a 
single exponential function were significantly different.   
In the case of 8 neurons no SICs occurred either in controls or during 
orexin use. In a further 13 cases orexin changed the appearance of SICs. 
In the 9 cases when SIC activity was low in controls, orexin changed 
the frequency from 0.057 ± 0.031/minute to 0.34 ± 0.08/minute, and 
increased charge transfer by SICs from 0.49 ± 0.26 pC/minute to 5.6 ± 
2.1 pC/minute.  In the four other cases where SIC activity was already 
high in the control (charge movement was above 2 pC/minute) orexin 
caused a significant decrease in SIC frequency and charge movement. 
Frequency decreased to 52 ± 12% of the control (from 0.52 ± 
0.05/minute to 0.28 ± 0.12/minute), with the corresponding decrease in 
charge movement being -32 ± 10% of the control (from 60.95 ± 30.6 
pC/minute to 22.7 ±12.4 pC/minute).   
When we plotted changes in the charge transfer of SICs against 
control charge transfer, fitting of the points revealed a linear 
25 
 
relationship.  When we plotted changes in the charge transfer of SICs as 
a function of changes in sEPSCs or the emerging tonic currents, we 
found no or only weak linear correlations.  
Comparison of the effect of orexin on SICs and the formerly 
published effects of other neuromodulators (muscarinic cholinergic, 
serotoninergic, and cannabinoid) on SICs showed that the effect of 
orexin on SICs did not differ from that of other neuromodulators. In 
sharp contrast, however, we found that while other neuromodulators 
can even evoke inward and outward tonic currents, orexin was 
characterised by a strong dominance of inward tonic currents.   
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DISCUSSION  
 
In this dissertation we sought to answer the question whether the 
„canonical” in vitro electrophysiological classification of PPN 
cholinergic neurons is valid for cholinergic neurons identified using 
transgenic techniques. We also investigated whether it was possible to 
establish a new classification or possibly a rostrocaudal gradient of 
functional properties. Another important question was whether 
orexinergic neuromodulation had an astrocyte-dependent component. If 
so, we wanted to find out whether this component was identical to the 
ones experienced during other neuromodulatory effects.  
In short, we concluded that the „canonical” electrophysiological 
classification of PPN cholinergic neurons is, indeed, valid for 
cholinergic neurons identified using transgenic techniques, too. We 
demonstrated the existence of two further groups of cholinergic neurons 
with A-current: the categories of early and late firing neurons. We 
demonstrated that early and late firing neurons as well as neurons 
showing low and high frequency membrane potential oscillation were 
present in different proportions along the rostrocaudal axis of the 
nucleus.   
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Further, we demonstrated that, in terms of its effect on SICs, the 
part of orexinergic neuromodulation through astrocytes is identical to 
that of other neuromodulators. The neuromodulatory effects on SICs 
probably form an aspecific, common component of the effects that 
change the activity of the neurons of the nucleus.  
 
Functional classification of PPN cholinergic neurons  
Based on our results we concluded that the ChAT-tdTomato 
mouse model is suitable for the examination of the functional properties 
of cholinergic neurons and its use enabled us to confirm the existence of 
previously described functional groups. Furthermore, we confirmed that 
cholinergic neurons were characterised by high threshold membrane 
potential oscillation. We also demonstrated that it determines action 
potential firing frequency.  
We demonstrated that the diverse functional groups of 
cholinergic neurons occur in different proportions in the caudal and 
rostral parts of the PPN. LTSs rarely elicit action potential in the 
cholinergic neurons of the PPN and this phenomenon was mostly found 
on rostrally located PPN neurons. We further classified neurons with A-
current into two subgroups. These are early and late firing neurons, of 
which the latter tended to be detected in the caudal part of the PPN.  
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HTOs that had higher frequency and lower power were detected on the 
caudal part of the PPN whereas HTOs with higher power and lower 
frequency tended to occur in the rostral part.  In addition, we concluded 
that HTOs showed higher amplitudes on somata than on proximal 
dendrites. 
Previous studies have used NADPH diaphorase, bNOS and 
ChAT immunohistochemical methods to identify cholinergic neurons.  
However, examination of membrane properties in genetically identified 
PPN cholinergic neurons has not taken place yet. In our experiments a 
negligible number of tdTomato-positive neurons were found to be 
ChAT-negative during immunohistochemical examinations. We can 
claim, in accordance with the literature, that the ChAT–tdTomato 
mouse model can be effectively used in the examination of the 
functional parameters of neurons. 
 
Neurons in the PPN have traditionally been classified into 3 
large groups based on their membrane properties. We integrated and 
unified the diverse markings in  the literature, creating a useful 
classification.  Type I neurons possess LTS caused by calcium 
conductances.  Type II neurons have A-current. Type III neurons 
possess both properties, whereas Type IIIK comoprises neurons that 
possess neither.   
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Roughly in accordance with literature data, our experiment 
carried out on transgenic mice revealed that only a minority (12%) of 
the examined neurons belonged to Type I, and most (48%) belonged to 
Type II. In our data analysis we were the first to establish that a greater 
proportion of Type II neurons were present in  the caudal part of the 
PPN with one third of rostrally located neurons belonging to this 
subgroup. In addition to the parameters used for grouping the only 
functional difference between the functional goups was that Type III 
neurons showed lower maximum firing frequency as a result of 
polarisation. 
In our study the presence of LTSs also showed a rostrocaudal 
gradient, and was a feature of rostrally located neurons. We found a 
further important relationship in relation to LTSs: neurons with LTSs 
possessed a bipolar dendritic tree, while those without LTSs tended to 
be multipolar.    
Our results have led us to conclude that the „canonical” 
classification used in the literature can still be used to describe the 
functional membrane properties of PPN neurons. The combination of 
the rostrocaudal differences of the presence of LTS and the low firing 
frequency of Type III neurons may suggest that the function of 
cholinergic neurons along the rostrocaudal axis may be different.  
A feature of Type II and III neurons is that they possess A- 
current, a transient, voltage gated potassium current which is known to 
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cause action potential delay compared to the beginning of the 
depoliarising stimulus. According to literary data, A-current latency 
varies between 50 and 500 ms. In the course of our examinations we 
classified PPN cholinergic neurons with A-current into early and late 
firing types. In addition, we could detect a correlation in the PPN 
between A-current kinetics and delay of the action potential delay.  As a 
further rostrocaudal difference we established that the late firing 
neurons tended to be located in the caudal part of the PPN. In addition 
to the role of the A-current in physiological action potential firing it is 
assumed to contribute to various patho-physiologocal processes, too.  It 
has been found  that the amplitude of the A- current of cardyomyocytes 
decreased in artificially induced inflammatory conditions. Accordingly, 
we can assume that neuroinflammatory processes can also affect the 
firing pattern of PPN cholinergic neurons by reducing A-current 
amplitude and action potantial delay contributing to  changes in sleep-
wakefulness cycles.   
 
High threshold oscillations can be detected in PPN cholinergic 
neurons. Literature data suggest that oscillation frequency varies 
between 4-16 Hz and 4-80 Hz across theta and beta domains. A 
characteristic feature of PPN cholinergic neurons is high-frequency 
oscillation regardless of „canonical” functional subgroups or 
morphological properties. Confirming literary data, in genetically 
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identified cholinergic neurons we detected low-frequency, high-
amplitude oscillations in the rostral part of the PPN. Cholinergic 
neurons with a caudal location were characterised by low-amplitude, 
high frequency oscillations. Our simultaneous recordings revealed that 
oscillation activity recorded on somata appears on the dendrites with 
lower amplitude but identical frequency and time. This led us to assume 
that the location of the emergence of the HTO is the soma, and the 
oscillation spreads passively towards the dendrite.  
We have also demonstrated that the frequency of HTOs is 
directly proportinal to the average firing frequency of the same neuron 
and inhibition of HTOs significantly increases firing potential. We find 
it probable that The relationship between membrane potential 
oscillations and action potential firing frequency is likely to be that the 
same ion channel set is responsible for both processes. 
As a summary we can conclude that we have confirmed 
existence of HTOs and demonstrated their rostracaudal differerences. It 
is likely that HTOs are generated in the somata rather than in the 
dendrites and are able to determine neuron action potential frequency.  
The diverse projections of the PPN are known to be 
topographically organised. Caudal PPNs provide input for the ventral 
tegmental area and the dorsomedial striatum while the rostral PPN 
innervates the area of substantia nigra pars compacta as well as the 
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dorsomedial striatum. These facts are in accordance with the already 
known differences between the caudal and rostral areas of the PPN. In 
our study we have demonstrated that several membrane properties 
possess rostrocaudal distribution. The presence of LTS is typical of 
cholinergic neurons in the rostral location whereas in the caudal area we 
found late-firing cholinergic neurons with slow A-current. In addition, 
the presence of HTOs (and the consequential firing frequency) also 
showed a rostrocaudal distribution. These in vitro rostrocaudal 
differences may account for the differences encountered in in vivo 
conditions. We assume that the in vitro results that we have 
demonstrated promote the design and assessment of further in vivo 
experiments that use a transgenic mouse model.  We also hope that the 
above data contribute to the understanding of the different outcomes of 
deep brain stimulation used therapeutically in different areas of the 
PPN. 
 
Investigtion of the effects of orexinergic neuromodulation on the 
PPN  
As a continuation of our laboratory studies, we examined the 
effect of orexin on the tonic neronal currents, EPSCs, and SICs of the 
PPN, and looked for correlations between these parameters and the 
33 
 
results of our earlier research exploring other neuromodular effects 
exerted on SICS. 
We found that, elicited by orexin, SIC activity increased when 
control activity was low, while in the case of high SIC activity in the 
control, it decreased.  The effect of orexin on SICs was independent 
from its effects on EPSCs and tonic inward currents. We found one 
important difference between orexin and other neuromodulators: orexin 
almost never elicited tonic outward current. 
It can be a matter of debate whether the astrocyte activation 
eliciting SICs is a direct or indirect effect of orexin. The orexinergic 
effect on SICs might also be a consequence of direct astrocytic action. It 
is well known that OX1R and OX2R receptors can also be detected in 
astrocyte cell cultures but there were no OX1R receptors in in situ PPN 
astrocytes, only in neurons.  Since OX2R can be found on both neurons 
and astrocytes in the PPN, it is plausible that their direct activation 
leads to the appearance of SICs. However, we can also assume that 
astrocytes react to the increased average neuronal activity.   
Another important issue is whether the effect of orexin on SICs 
can be regarded as a model of physiological phenomena or it 
respresents pathophysiological mechanisms. The number of orexin 
receptors and glutamate transporters increases in certain 
neurodegenerative diseases and cerebral ischemia and can play a 
protective role in these processes. 
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We assume that SICs and orexinergic effects on SICs are present in 
physiological conditions, too, but probably intensify in pathological 
conditions.  
The effects of various neuromodulators and agonists on SICs depend on 
the SIC activity of the control. A possible explanation for this is that 
astrocytes, responding to increased neuronal effects under the effect of 
neuromodulators, increase extrasynaptic glutamate concentration. If 
extrasynaptic glutamate concentration was originally low, the increase 
in glutamate level activates extrasynaptic NMDA receptors, leading to 
an increase in SIC activity. If original extrasynaptic glutamate 
concentration was high, a further increase in glutamate level results in 
NMDA receptor desensitisations. . 
Our results support the theory that SICs are uniformly 
modulated by various neuromodulatory mechanisms in the PPN, 
contributing to the emergence of a common, astrocyte dependent 
component of neuromodulatory mechanisms. This astrocyte dependent 
component is presumably not or only partly is a consequency of the 
direct activation of astrocytes, instead, it is a response to the neuronal 
activity altered by neuromodulators. SICs in the PPN might be part of 
an astrocyte dependent homeostatic regulation.  
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SUMMARY  
The pedunculopontine nucleus is a cholinergic nucleus of the 
reticular activation system. Its physiological significance lies in the fact 
that it plays an important role in the regulation of sleep-wakefulness 
cycles, sensory gating, and movement regulation.   
Although the nucleus is known as a cholinergic structure, large 
numbers of GABAergic and glutamergic neurons are also present there.  
Several attempts have been made to classify PPN neurons. The 
classification based on in vitro experiments distinguished 3 or 4 
functional groups based on the presence of A-current and low threshold 
membrane potential dendrites.  
In the first part of this work we revised an earlier grouping based 
on post hoc neurochemical cell identification using cell identification 
based on transgenic technique.  We concluded that cholinergic neurons 
with A-current can further be divided into two subgroups: that of early-
firing and late-firing neurons.  We also demonstrated that A-current, 
low-threshould spikes and high-threshold membrane potential 
oscillations all showed varying distribution along the rostrocaudal axis. 
The differences along the rostrocaudal axis can be a cell-level 
elecrophysiological explanation for the locally different outcomes of 
deep brain stimulation in Parkinson’s disease.  
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The PPN is a target for several neuromodulatory mechanisms 
affecting sleep-wakefulness cycles.  In our earlier work we 
demonstrated that cholinergic, serotoninergic and cannabinoid 
neuromodulatory effects had overlapping, astrocyte-dependent 
components, too.  Some of these were tonic inward and outward 
currents evoked by astrocyte activity and the composite effect on phasic 
slow inward currents (SICs).   
Orexinergic neuromodulation somewhat differs from the ones 
studied so far since it known to cause the homogenous depolarisation of 
neurons rather than the different tonic effects.  Our aim was to examine 
the effect of orexin on SICs.  We concluded that if starting SIC activity 
was low, it was increased by orexin, whereas if SIC activity was high in 
control conditions, it was decreased by it.  This phenomenon probably 
caused by NMDA receptor activation or desensitisation was the same as 
all neuromodulatoty effects that we examined.  The observed 
phenomenon is a probably aspecific, common, astrocyte-dependent 
component of the neuromodulary actions which might be capable of 
regulating neuronal desychronisation.  
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